Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Februar 2015 09:00 ET | Quelle: CardioGenics Holdings Inc.

USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application

MISSISSAUGA, Ontario, Feb. 17, 2015 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and...
17. Februar 2015 07:00 ET | Quelle: SITO Mobile, Ltd.

SITO Mobile Issued New Mobile Technology Patent

JERSEY CITY, N.J., Feb. 17, 2015 (GLOBE NEWSWIRE) -- SITO Mobile Ltd. (OTCQB:SITO), a leading mobile engagement platform provider, today announced that its subsidiary SITO Mobile R&D IP, LLC has...
13. Februar 2015 11:56 ET | Quelle: Associa

Association Services of Florida's Marc Rodriguez Elected to Builders Association Board

MIRAMAR, Fla., Feb. 13, 2015 (GLOBE NEWSWIRE) -- Marc Rodriguez, vice president at Association Services of Florida (ASF), an Associa Company, has been elected to the Board of Directors for the...
12. Februar 2015 16:11 ET | Quelle: The John Marshall Law School-Chicago

Counterfeit Merchandise and a Jury's Impact on Patent Law: Chicago's John Marshall Law School Hits Hot Topics in Intellectual Property Law

CHICAGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- What is the best way to handle a trademark/copyright counterfeiting case? Can the use of jury research give you the upper hand in patent cases? Those topics...
10. Februar 2015 08:15 ET | Quelle: Lion Biotechnologies, Inc.

Lion Biotechnologies Obtains Exclusive License From NIH to Develop and Commercialize TIL Therapy in Metastatic Melanoma

LOS ANGELES, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL),...
10. Februar 2015 08:00 ET | Quelle: Cara Therapeutics

Cara Therapeutics Issued Additional U.S. Patent Covering the Expanded Use of Kappa Opioid Receptor Agonist CR845 and Analogs for the Treatment and Prevention of Pain-Related Conditions

SHELTON, Conn., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
09. Februar 2015 08:41 ET | Quelle: Malibu Boats, Inc.

Malibu and Nautique Settle Wakesurfing Patent Litigation

LOUDON, Tenn., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Malibu Boats, LLC, the leading innovator and pioneer of modern wakesurfing technology, including the standard-setting Surf Gate system, today announced...
06. Februar 2015 08:00 ET | Quelle: VBL Therapeutics

VBL Therapeutics Receives European Patent Issuance on Lecinoxoid Platform Technology

TEL AVIV, Israel, Feb. 6, 2015 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company committed to the discovery, development and commercialization of...
03. Februar 2015 18:00 ET | Quelle: MediciNova, Inc.

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of NASH

LA JOLLA, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
03. Februar 2015 00:01 ET | Quelle: Cloud-MD

National Scientific Corporation a/k/a CipherLoc Corporation Announces Two New Patent Applications for Securing the IoT Devices

HENDERSON, Nev., Feb. 3, 2015 (GLOBE NEWSWIRE) -- National Scientific Corporation (OTCQB:NSCT), announced today that it has filed for two new patents on its CipherLoc Polymorphic Cipher Engine...

Vorherige Seite

Nächste Seite